Sunrise

Sunrise develops smart devices and apps for monitoring and managing sleep data, featuring a device attached to the chin during sleep to record detailed sleep metrics. The app tracks and analyzes sleep patterns to diagnose sleep disorders including sleep apnea, providing clinical-grade sleep monitoring in a home setting. The device captures mandibular movement patterns that enable accurate detection of sleep stages, respiratory events, and other sleep-related parameters, offering an alternative to traditional polysomnography conducted in sleep labs. Sunrise's technology enables accessible, comfortable sleep diagnostics for the millions of people affected by undiagnosed sleep disorders. Founded in 2013 and headquartered in Namur, Belgium, Sunrise has raised approximately $52.8 million in Series C funding from investors including the Alexa Fund, EIC Fund, Eurazeo, Kurma Partners, and Vives Fund.